Literature DB >> 19286686

Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation.

D Ellenberg1, J Shi, S Jain, J-H Chang, H Ripps, S Brady, E R Melhem, F Lakkis, A Adamis, D-F Chen, R Ellis-Behnke, R S Langer, S M Strittmatter, D T Azar.   

Abstract

Maintenance of ocular viability is one of the major impediments to successful whole-eye transplantation. This review provides a comprehensive understanding of the current literature to help guide future studies in order to overcome this hurdle. A systematic multistage review of published literature was performed. Three specific questions were addressed: (1) Is recovery of visual function following eye transplantation greater in cold-blooded vertebrates when compared with mammals? (2) Is outer retina function following enucleation and reperfusion improved compared with enucleation alone? (3) Following optic-nerve transection, is there a correlation between retinal ganglion cell (RGC) survival and either time after transection or proximity of the transection to the globe? In a majority of the studies performed in the literature, recovery of visual function can occur after whole-eye transplantation in cold-blooded vertebrates. Following enucleation (and reperfusion), outer retinal function is maintained from 4 to 9 h. RGC survival following optic-nerve transection is inversely related to both the time since transection and the proximity of transection to the globe. Lastly, neurotrophins can increase RGC survival following optic-nerve transection. This review of the literature suggests that the use of a donor eye is feasible for whole-eye transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19286686      PMCID: PMC2850278          DOI: 10.1136/bjo.2008.155267

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  81 in total

1.  RETURN OF VISION IN LARVAL EYES EXCHANGED BETWEEN AMBLYSTOMA PUNCTATUM AND THE CAVE SALAMANDER, TRYPHLOTRITON SPELAEUS.

Authors:  L S STONE
Journal:  Invest Ophthalmol       Date:  1964-12

2.  The role of neural mechanisms in the regulation of intraocular pressure in the cat.

Authors:  P P LELE; P GRIMES
Journal:  Exp Neurol       Date:  1960-06       Impact factor: 5.330

3.  Acetazolamide and the venous pressure of the eye.

Authors:  F J MACRI
Journal:  Arch Ophthalmol       Date:  1960-06

4.  Intravitreal transplants of Schwann cells and fibroblasts promote the survival of axotomized retinal ganglion cells in rats.

Authors:  Shengxiu Li; Bing Hu; David Tay; Kwok-Fai So; Henry Ka-Fun Yip
Journal:  Brain Res       Date:  2004-12-10       Impact factor: 3.252

5.  Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo.

Authors:  Paul Lingor; Paulo Koeberle; Sebastian Kügler; Mathias Bähr
Journal:  Brain       Date:  2005-01-19       Impact factor: 13.501

6.  Multifocal electroretinography in isolated arterially perfused bovine eye.

Authors:  Mohammad Shahidullah; Henry H L Chan; Maurice K Yap; Quan Liu; Chi-Ho To
Journal:  Ophthalmic Physiol Opt       Date:  2005-01       Impact factor: 3.117

7.  Protective effect of donepezil on retinal ganglion cells in vitro and in vivo.

Authors:  Atsuya Miki; Yasumasa Otori; Takeshi Morimoto; Masaki Okada; Yasuo Tano
Journal:  Curr Eye Res       Date:  2006-01       Impact factor: 2.424

8.  Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy.

Authors:  D C Baptiste; K J Powell; C A B Jollimore; C Hamilton; T L LeVatte; M L Archibald; B C Chauhan; G S Robertson; M E M Kelly
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

9.  Ciliary neurotrophic factor protects retinal ganglion cells from axotomy-induced apoptosis via modulation of retinal glia in vivo.

Authors:  B A van Adel; J M Arnold; J Phipps; L C Doering; A K Ball
Journal:  J Neurobiol       Date:  2005-06

10.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

View more
  9 in total

1.  Total Human Eye Allotransplantation: Developing Surgical Protocols for Donor and Recipient Procedures.

Authors:  Edward H Davidson; Eric W Wang; Jenny Y Yu; Juan C Fernandez-Miranda; Dawn J Wang; Nikisha Richards; Maxine Miller; Joel S Schuman; Kia M Washington
Journal:  Plast Reconstr Surg       Date:  2016-12       Impact factor: 4.730

Review 2.  Whole-eye transplantation: a look into the past and vision for the future.

Authors:  D Bourne; Y Li; C Komatsu; M R Miller; E H Davidson; L He; I A Rosner; H Tang; W Chen; M G Solari; J S Schuman; K M Washington
Journal:  Eye (Lond)       Date:  2016-12-16       Impact factor: 3.775

Review 3.  Traumatic optic neuropathy: a review.

Authors:  Arjunan Muthu Kumaran; Gangadhara Sundar; Lim Thiam Chye
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-25

4.  Cellular Mechanisms of Rejection of Optic and Sciatic Nerve Transplants: An Observational Study.

Authors:  Merve Yonar; Mayuko Uehara; Naima Banouni; Vivek Kasinath; Xiaofei Li; Liwei Jiang; Jing Zhao; Fengfeng Bei; Su Ryon Shin; Curtis L Cetrulo; Nasim Annabi; Reza Abdi
Journal:  Transplant Direct       Date:  2020-07-24

Review 5.  Clinical Considerations for Vascularized Composite Allotransplantation of the Eye.

Authors:  Edward H Davidson; Eric W Wang; Jenny Y Yu; Juan C Fernandez-Miranda; Dawn J Wang; Yang Li; Maxine Miller; Wesley N Sivak; Debra Bourne; Hongkun Wang; Mario G Solari; Joel S Schuman; Kia M Washington
Journal:  J Craniofac Surg       Date:  2016-10       Impact factor: 1.046

Review 6.  Ethical Considerations of Whole-Eye Transplantation.

Authors:  Wesley N Sivak; Edward H Davidson; Chiaki Komatsu; Yang Li; Maxine R Miller; Joel S Schuman; Mario G Solari; Gerard Magill; Kia M Washington
Journal:  J Clin Ethics       Date:  2016

7.  Ophthalmic transplantology: anterior segment of the eye - part I.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-05

Review 8.  Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.

Authors:  Tyler Bahr; Kyle Welburn; Jonathan Donnelly; Yidong Bai
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-02-24       Impact factor: 6.633

Review 9.  Nanomedicine approaches for corneal diseases.

Authors:  Shyam S Chaurasia; Rayne R Lim; Rajamani Lakshminarayanan; Rajiv R Mohan
Journal:  J Funct Biomater       Date:  2015-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.